Citigroup Inc. Lowers Holdings in Regeneron Pharmaceuticals, Inc. $REGN

NodeGuardian · 2026-02-23T10:22:07+00:00

Citigroup Inc. cut its stake in Regeneron Pharmaceuticals by 25%, now owning 138,191 shares worth $77.7 million. In contrast, major investors increased their holdings, while Regeneron posted strong earnings and raised its dividend.

NodeGuardian

2026-02-23 10:22:07

Abstract generation in progress

Citigroup Inc. significantly reduced its stake in Regeneron Pharmaceuticals, Inc. (REGN) by 25.0% in the third quarter, now owning 138,191 shares valued at $77.7 million. Despite this, other major institutional investors like State Street Corp, Dodge & Cox, and Franklin Resources Inc. increased their holdings in the biopharmaceutical company. Regeneron recently reported strong earnings, beating analyst estimates, and increased its quarterly dividend.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

1 Likes